Education
About Us
Working with TipRanks
Follow Us
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
BioCryst (BCRX) Ownership Overview
1.58% Insiders
17.68% Mutual Funds
31.49% Other Institutional Investors
16.09% ETFs
33.17% Public Companies and Individual Investors
The ownership structure of BioCryst (BCRX) stock is a mix of institutional, retail, and individual investors. Approximately 65.26% of the company’s stock is owned by Institutional Investors, 1.58% is owned by Insiders, and 33.17% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $303960 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $1020772 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2362500 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $22891027 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,145,627 | Institution | 7.72% | 167,430,152 | |
| 13,834,553 | Institution | 6.61% | 143,464,315 | |
| 9,902,044 | Institution | 4.73% | 102,684,196 | |
| 5,189,665 | Institution | 2.48% | 53,816,826 | |
| 4,118,070 | Institution | 1.97% | 42,704,386 | |
| 3,148,169 | Institution | 1.50% | 32,646,513 | |
| 3,052,137 | Institution | 1.46% | 31,650,661 | |
| 2,613,790 | Institution | 1.25% | 27,105,002 | |
| 2,196,795 | Institution | 1.05% | 22,780,764 | |
| 2,053,359 | Institution | 0.98% | 21,293,333 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,834,553 | Institution | 6.61% | 143,464,315 | |
| 4,118,070 | Institution | 1.97% | 42,704,386 | |
| 2,613,790 | Institution | 1.25% | 27,105,002 | |
| 2,196,795 | Institution | 1.05% | 22,780,764 | |
| 2,053,359 | Institution | 0.98% | 21,293,333 | |
| 2,021,487 | Institution | 0.97% | 20,962,820 | |
| 1,382,671 | Institution | 0.66% | 14,338,298 | |
| 1,150,686 | Institution | 0.55% | 11,932,614 | |
| 857,852 | Institution | 0.41% | 8,895,925 | |
| 728,181 | Institution | 0.35% | 7,551,237 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,691,811 | Institution | 3.20% | 59,222,527 | |
| 5,207,064 | Institution | 2.49% | 53,997,254 | |
| 3,226,521 | Institution | 1.54% | 28,554,711 | |
| 2,774,656 | Institution | 1.33% | 28,856,422 | |
| 2,625,446 | Institution | 1.25% | 23,235,197 | |
| 1,763,223 | Institution | 0.84% | 18,284,623 | |
| 1,459,722 | Institution | 0.70% | 12,918,540 | |
| 1,196,095 | Institution | 0.57% | 12,403,505 | |
| 1,029,967 | Institution | 0.49% | 9,115,208 | |
| 983,471 | Institution | 0.47% | 10,228,098 |
FAQ
Who Owns Biocryst Pharmaceuticals (BCRX)?
According to the latest TipRanks data, approximately 31.49% of the company's stock is held by institutional investors, 1.58% is held by insiders, and 33.17% is held by retail investors.
What percentage of Biocryst Pharmaceuticals (BCRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.49% of Biocryst Pharmaceuticals (BCRX) stock is held by institutional investors.
What percentage of Biocryst Pharmaceuticals (BCRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.17% of Biocryst Pharmaceuticals (BCRX) stock is held by retail investors.
Who owns the most shares of Biocryst Pharmaceuticals (BCRX)?
Vanguard owns the most shares of Biocryst Pharmaceuticals (BCRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.